{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:22:30Z","timestamp":1793877750836,"version":"4.7.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>In the context of idiopathic pulmonary fibrosis (IPF), respiratory-related admissions to hospital are associated with a high morbidity and short-term mortality with significant burden on secondary care services. It has yet to be determined how to accurately identify patients at risk of acute respiratory deterioration (ARD) or the prognosticating factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>We sought to define the characteristics of hospitalized ARD-IPF patients in a real-world cohort and investigate factors associated with worse outcomes. Specifically, we wished to determine the association between baseline CURB-65 and NEWS-2 and mortality in IPF, given illness severity scores have not previously been validated in this cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Single-centre retrospective observational cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 172 first hospitalizations for ARD, 27 admissions (15.7%) were due to an acute exacerbation of IPF (AE-IPF), 28 (16.3%) secondary to cardiac failure\/fluid overload and 17 due to pneumonia (9.9%). Other admissions related to lower respiratory tract infection, extra-parenchymal causes and those without a specific trigger. Baseline patient characteristics were comparable for all underlying aetiologies of ARD-IPF. Treatment pathways did not differ significantly between AE-IPF and other causes of ARD-IPF. Short-term mortality was high, with \u223c22% patients dying within 30\u2009days. Illness severity scores (NEWS-2 and CURB-65) were independent predictors of mortality in multivariable logistic regression modelling.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings suggest significant mortality related to hospitalization with ARD-IPF of any underlying cause. Our data support the use of CURB-65 and NEWS-2 scores as illness severity scores that can provide a simple tool to help future prognostication in IPF. Research should be aimed at refining the management of these episodes, to try to reduce mortality, where possible, or to facilitate palliative care for those with adverse prognostic characteristics.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/qjmed\/hcaa214","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T19:16:14Z","timestamp":1592939774000},"page":"559-567","source":"Crossref","is-referenced-by-count":4,"title":["Utility of illness severity scores to predict mortality in patients hospitalized with respiratory deterioration of idiopathic pulmonary fibrosis"],"prefix":"10.1093","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3923-1773","authenticated-orcid":false,"given":"C","family":"Hyams","sequence":"first","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust Southmead Road, Bristol BS10 5NB, UK"},{"name":"Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead Road, Bristol BS10 5NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Hettle","sequence":"additional","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust Southmead Road, Bristol BS10 5NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bibby","sequence":"additional","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust Southmead Road, Bristol BS10 5NB, UK"},{"name":"Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead Road, Bristol BS10 5NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H A","family":"Adamali","sequence":"additional","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust Southmead Road, Bristol BS10 5NB, UK"},{"name":"Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead Road, Bristol BS10 5NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-7349","authenticated-orcid":false,"given":"S L","family":"Barratt","sequence":"additional","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust Southmead Road, Bristol BS10 5NB, UK"},{"name":"Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead Road, Bristol BS10 5NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"2021110616401190400_hcaa214-B1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110616401190400_hcaa214-B2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110616401190400_hcaa214-B3","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110616401190400_hcaa214-B4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110616401190400_hcaa214-B5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.rmed.2018.09.011","article-title":"Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis","volume":"143","author":"Teramachi","year":"2018","journal-title":"Respir Med"},{"key":"2021110616401190400_hcaa214-B6","doi-asserted-by":"crossref","first-page":"e0166462","DOI":"10.1371\/journal.pone.0166462","article-title":"Burden of idiopathic pulmonary fibrosis progression: a 5-year longitudinal follow-up study","volume":"12","author":"Cottin","year":"2017","journal-title":"PLoS One"},{"key":"2021110616401190400_hcaa214-B7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1378\/chest.13-2424","article-title":"Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort study","volume":"147","author":"Brown","year":"2015","journal-title":"Chest"},{"key":"2021110616401190400_hcaa214-B8","doi-asserted-by":"crossref","first-page":"A236.1","DOI":"10.1136\/thoraxjnl-2016-209333.415","article-title":"Epidemiology of idiopathic pulmonary fibrosis in the UK: findings of the British lung foundation's \u2018Respiratory health of the Nation\u2019 project","volume":"71","author":"Snell","year":"2016","journal-title":"Thorax"},{"key":"2021110616401190400_hcaa214-B9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"2021110616401190400_hcaa214-B10","first-page":"e6613","article-title":"DECAF versus CURB-65 to foresee mortality among patients presenting with an acute exacerbation of chronic obstructive pulmonary disease","volume":"12","author":"Ahmed","year":"2020","journal-title":"Cureus"},{"key":"2021110616401190400_hcaa214-B11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1440-1843.2010.01866.x","article-title":"Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score","volume":"16","author":"Chang","year":"2011","journal-title":"Respirology"},{"key":"2021110616401190400_hcaa214-B12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1513\/AnnalsATS.201403-102OC","article-title":"Early warning system scores for clinical deterioration in hospitalized patients: a systematic review","volume":"11","author":"Smith","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2021110616401190400_hcaa214-B13","author":"Smith","year":"2014"},{"key":"2021110616401190400_hcaa214-B14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1108\/IJHCQA-07-2015-0086","article-title":"Early warning scores: unravelling detection and escalation","volume":"28","author":"Smith","year":"2015","journal-title":"Int J Health Care Qual Assur"},{"key":"2021110616401190400_hcaa214-B15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.15441\/ceem.19.036","article-title":"Use of the National Early Warning Score for predicting in-hospital mortality in older adults admitted to the emergency department","volume":"7","author":"Kim","year":"2020","journal-title":"Clin Exp Emerg Med"},{"key":"2021110616401190400_hcaa214-B16","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/CCM.0000000000002000","article-title":"A comparison of the ability of the physiologic components of medical emergency team criteria and the U.K. national early warning score to discriminate patients at risk of a range of adverse clinical outcomes","volume":"44","author":"Smith","year":"2016","journal-title":"Crit Care Med"},{"key":"2021110616401190400_hcaa214-B17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1183\/09059180.00002114","article-title":"Staging of idiopathic pulmonary fibrosis: past, present and future","volume":"23","author":"Kolb","year":"2014","journal-title":"Eur Respir Rev"},{"key":"2021110616401190400_hcaa214-B18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MCP.0000000000000073","article-title":"Acute exacerbations complicating interstitial lung disease","volume":"20","author":"Ryerson","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"2021110616401190400_hcaa214-B19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.chest.2015.12.026","article-title":"Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis","volume":"149","author":"Moua","year":"2016","journal-title":"Chest"},{"key":"2021110616401190400_hcaa214-B20","first-page":"103","article-title":"Risk factors of acute exacerbation of idiopathic pulmonary fibrosis","volume":"27","author":"Kondoh","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2021110616401190400_hcaa214-B21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2169\/internalmedicine.9331-17","article-title":"Prognostic factors in the acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study","volume":"57","author":"Atsumi","year":"2018","journal-title":"Intern Med"},{"key":"2021110616401190400_hcaa214-B22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000353580","article-title":"Idiopathic pulmonary fibrosis: diagnosis and prognostic evaluation","volume":"86","author":"Poletti","year":"2013","journal-title":"Respiration"},{"key":"2021110616401190400_hcaa214-B23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12931-014-0109-y","article-title":"Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis","volume":"15","author":"Oda","year":"2014","journal-title":"Respir Res"},{"key":"2021110616401190400_hcaa214-B24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1590\/1414-431X20132885","article-title":"Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation","volume":"46","author":"Santos","year":"2013","journal-title":"Braz J Med Biol Res"},{"key":"2021110616401190400_hcaa214-B25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000329891","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors","volume":"83","author":"Simon-Blancal","year":"2012","journal-title":"Respiration"},{"key":"2021110616401190400_hcaa214-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/5160694","article-title":"The role of infection in acute exacerbation of idiopathic pulmonary fibrosis","volume":"2019","author":"Weng","year":"2019","journal-title":"Mediators Inflamm"},{"key":"2021110616401190400_hcaa214-B27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1465-9921-14-73","article-title":"Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials","volume":"14","author":"Collard","year":"2013","journal-title":"Respir Res"},{"key":"2021110616401190400_hcaa214-B28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1378\/chest.14-2889","article-title":"The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes","volume":"148","author":"Andrade","year":"2015","journal-title":"Chest"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcaa214\/33527206\/hcaa214.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/114\/8\/559\/41098804\/hcaa214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/114\/8\/559\/41098804\/hcaa214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T16:40:35Z","timestamp":1636216835000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/114\/8\/559\/5865873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,7,1]]},"published-print":{"date-parts":[[2021,11,5]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcaa214","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2020,7,1]]}}}